Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT01590433
Clinical Trials · NCT01590433
Weight Loss With Exenatide Treatment
Completed
Phase 4
Exenatide
(Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Jody Dushay
Enrollment
249
Start date
Mar 2012
Locations
1 site, United States
Primary endpoint
Change in Body Weight
View Exenatide compound reference